Author Details

Ferrario, Matteo, Direzione Market Access Roche SpA, Milano

  • Vol 18, No 1 (2017) - Letter to the Editor
    [In reference to "Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]
    Details  HTML  PDF